ISRCTN14732216已完成未知
Efecctiveness of of the quadrivalent human papillomavirus (qHPV) vaccine in HIV-positive Spanish men having sex with men (MSM): a double-blind randomised clinical trial
Fundacion Progreso Y Salud, Consejeria De Salud Y Bienestar Social (Progress and Health Foundation, Ministry of Health and Social Welfare)0 个研究点目标入组 120 人开始时间: 2016年8月2日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 120
研究概览
简要总结
2017 Results article in https://www.ncbi.nlm.nih.gov/pubmed/28720147 results 2017 Results article in https://www.ncbi.nlm.nih.gov/pubmed/28729879 results 2021 Results article in https://doi.org/10.3390/v13020144 (added 12/09/2023)
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- Male
入选标准
- •1. HIV-positive MSM patients
- •2. >18 years of age
- •3. Those who, at the time of inclusion into the study, had not been infected simultaneously by the 4 genotypes of HPV that the quadrivalent vaccine addresses
- •4. Patients who had high-resolution anoscopy (HRA) screening for inclusion are normal or had only condylomas and/or low squamous intraepithelial lesion (LSIL) in anal biopsy
排除标准
- •1. HIV positive MSM (Men Who Have Sex with Men)
- •2. Simultaneous anal infection caused by the 4 genotypes addressed by the vaccine, or at least HPV16
- •3. Aged 18 years and over
- •4. Active opportunist infection at the time of recruitment into the study
- •5. Patients who, in screening anoscopy had HSIL, or ASCC or having received treatment for these lesions
- •6. History of allergy to aluminium and/or yeast extract excipient
研究者
相似试验
进行中（未招募）
1 期
AEUCTR2016-002455-20-FRASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)
已完成
不适用
Efficacy of quadrivalent human papillomavirus vaccine (Gardasil) for recurrent respiratoru papillomatosisrecurrent respiratory papillomatosisJPRN-UMIN000020352Kanazawa University5
已完成
3 期
Safety, Tolerability and Immunogenicity of HPV (Human Papilloma Virus) Vaccine in Healthy Females 9 to 15 Years of Age in India (V501-029)Papillomavirus InfectionsNCT00380367Merck Sharp & Dohme LLC110
已完成
2 期
Safety, Reactogenicity, Immunogenicity, Efficacy of Influenza Vaccines Grippol® Quadri and Grippol® Plus in VolunteersInfluenzaNCT03849560NPO Petrovax612
已完成
4 期
Immunogenicity and Safety of a Quadrivalent Human Papillomavirus (HPV) Vaccine in Patients With SLE: a Controlled StudySystemic Lupus ErythematosusNCT00911521Tuen Mun Hospital100